Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002220:Carbamazepine / Q000494:pharmacology*; D004347:Drug Interactions; D006591:Hexobarbital / Q000494:pharmacology; D007555:Isoxazoles / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D010080:Oxazoles / Q000494:pharmacology*; D010634:Phenobarbital / Q000494:pharmacology*; D010672:Phenytoin / Q000494:pharmacology*; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013997:Time Factors
D000927:Anticonvulsants; D007555:Isoxazoles; D010080:Oxazoles; D002220:Carbamazepine; D010672:Phenytoin; D011335:Proadifen; D006591:Hexobarbital; D010634:Phenobarbital